Portugal's First Hundred Specialist Pharmacists Qualify in 2027. Their Regulator Wants the SNS Posts Opened Now.
The Residência Farmacêutica started in 2023 and reaches its first finish line next year, in clinical analyses, hospital pharmacy and human genetics. More than 500 pharmacists are behind them in the programme.
At the start of next year about a hundred pharmacists in Portugal will sit their final assessments and become the country's first formally qualified specialists in hospital pharmacy, clinical analyses and human genetics. Their regulator spent Monday asking the health service to decide, now rather than later, whether it intends to employ any of them.
The Ordem dos Farmacêuticos said in a statement that the SNS should open the posts needed to absorb the roughly one hundred professionals due to complete their specialisation in 2027, and should start preparing the recruitment now. The warning attached to the request was blunt. "The preparation of the recruitment processes must go ahead as soon as possible," the bastonário, Hélder Mota Filipe, said, "avoiding a situation in which the absence of any prospect of being taken on leads these pharmacists to look for opportunities elsewhere and compromises the return on that investment in the quality of care provided to the population."
A four-year programme reaching its first finish line
The Residência Farmacêutica began in Portugal at the start of 2023. It is a four-year specialisation running in three areas: clinical analyses, hospital pharmacy and human genetics. The cohort finishing next year is the first to complete it, which makes 2027 the year the qualification stops being a plan and starts producing people.
The scale behind that first cohort is larger than it looks. More than 500 pharmacists are currently in the residency across the three areas, so the hundred qualifying in 2027 are the leading edge of an annual flow that the health service will have to keep absorbing, or keep losing.
The career question
Mota Filipe called the completion of the first cycle a milestone for the profession and for the SNS, and said the health service should now guarantee that these pharmacists are integrated into the pharmacist career. The Ordem's position is that it makes no sense to spend public money training highly qualified professionals without creating the conditions for them to stay in the services where they are needed.
That is a familiar argument in Portuguese health policy, and it has usually been made about doctors and nurses. The pharmacist version has a particular edge, because the three specialities involved sit in exactly the places where a hospital cannot improvise: the laboratory that runs the clinical analyses, the pharmacy that prepares and dispenses what the wards use, and the genetics service that an increasing share of modern diagnosis depends on.
Timing is the whole of the request
Nothing in the Ordem's statement asks for a change of policy. What it asks for is a calendar. Public recruitment in Portugal moves through published notices, ranking lists and appeal periods, and a competition opened after the assessments are done will still be running months later, by which point a newly qualified specialist with a four-year specialisation and no job offer has had ample time to take one abroad or in the private sector.
The health ministry has not yet responded publicly to the request. It arrives in a month in which the SNS workforce has been under pressure from several directions at once, from departures at a Lisbon children's hospital to the pay order for emergency rotas, and the government is preparing a state budget in which every new staffing commitment has to be counted.